
2269 · Wuxi Biologics (Cayman) Inc.
51.00
HKDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
HK$205.76B
PE
23.80
EV/EBITDA
13.6
DIV Yield
0%
Payout Ratio
0%
MQV Rating
4Weak
As at 21/08/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- Defying Gravity
- HALO 100
- HALO 200
- HALO 50
- HALO All
- HALO Price Momentum
- Near Resistance
Key Fundamentals
EPS 3 yr Growth
15.00%
EBITDA Margin
38.50%
Operating Cashflow
¥6,558m
Free Cash Flow Return
14.00%
ROIC
10.50%
Interest Coverage
58.60
Quick Ratio
3.00
Performance
52 weeks range
Low 28.48 - 51.55
Trade Value (12mth)
US$39,862,763.00
1 week
8.57%
1 month
26.5%
YTD
52.55%
1 year
61.17%
All time high
148.00
Additional Data
Shares Outstanding (Fully Diluted)
4,167m
HALO Sector
Healthcare
Next Company Report Date
23-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
CNY
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Very Strong
Earnings
Very Weak
Growth
Earnings
Weak
Dividends
Very Weak
Quality
Capital Efficiency
Neutral
Balance Sheet
Strong
Valuation
News & Announcements
| Date | Event |
20 August 25Flash | |
26 March 25Flash | |
23 August 24Flash |
Key Stakeholders
| Name | Title |
| Wuxi Biologics Holdings Ltd. | Private Company |
| Zhi Sheng Chen | Individual |
| Invesco Great Wall Fund Management Co. Ltd. | Joint Venture |
| Wei Chang Zhou | Individual |
| Xue Jun Gu | Individual |